Table 4. Brachial artery studies after supplementation. Data are means (± SE).
|
Folic Acid Group
(n = 8) |
Placebo Group
(n = 5) |
| Heart rate (min) |
61 (6) |
54 (4) |
| Mean arterial pressure |
|
|
| Systolic (mmHg) |
102.5 (1.1 ) |
104.4 (3.0) |
| Diastolic (mmHg) |
65.3 (1.6) |
61.0 (4.0 ) |
| Temperature (°C) |
23.1 (.8) |
25.0 (.0) * |
| Humidity |
42.2 (2.5) |
46.4 (.9) |
| Baseline brachial artery diameter (mm) |
3.1 (.1 ) |
3.52 (.1) ** |
| Peak brachial artery diameter (mm) |
3.4 (.1) |
3.8 (.1) * |
| Flow-mediated dilation (%) |
10.0 (.9) |
6.65 (.7) * |
| Peak change in flow velocity (%) |
100.2 (10.0 ) |
110.4 (8.9) |
* and ** denote p < 0.05 and 0.01 respectivelyaccording to Exact Wilcoxon Rank-Sum Test.
